PTC Therapeutics, Inc. Cost of Goods Sold (Deprecated 2018-01-31)
PTC Therapeutics, Inc. (PTCT) reported Cost of Goods Sold (Deprecated 2018-01-31) of $3.04 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-05-09
- PTC Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $3.04M, a 7707.69% increase year-over-year.
- PTC Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $2.44M.
- PTC Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $1.58M.
- PTC Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $758.00K.
- PTC Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $4.58M.
- PTC Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $0.00.
- PTC Therapeutics, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $0.00.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $3.04M 10-Q · filed 2018-05-09 | $5.48M derived: sum of 2 quarters · filed 2018-05-09 | $7.06M derived: sum of 3 quarters · filed 2018-05-09 | $7.82M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $4.02M derived: sum of 2 quarters · filed 2018-03-06 | $4.78M derived: sum of 3 quarters · filed 2018-03-06 | $4.58M 10-K · filed 2018-03-06 |
| 2017-09-30 | $1.58M 10-Q · filed 2017-11-02 | $2.34M derived: sum of 2 quarters · filed 2017-11-02 | $2.14M 10-Q · filed 2017-11-02 | $2.38M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-06-30 | $758.00K 10-Q · filed 2017-08-09 | $797.00K 10-Q · filed 2017-08-09 | $797.00K derived: sum of 3 quarters · filed 2018-05-09 | $797.00K derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-03-31 | $39.00K 10-Q · filed 2018-05-09 | $39.00K derived: sum of 2 quarters · filed 2018-05-09 | $39.00K derived: sum of 3 quarters · filed 2018-05-09 | $39.00K derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $0.00 derived: sum of 2 quarters · filed 2018-03-06 | $0.00 derived: sum of 3 quarters · filed 2018-03-06 | $0.00 10-K · filed 2018-03-06 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-08 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |